The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
6 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $1,387,230 in first-year total cost, median $199,964.
Most frequent study sections
- Special Emphasis Panel[ZEB1 OSR-F (J2)]5
- Special Emphasis Panel[ZEB1 OSR-F (O1)]1
Most frequent institutions
- AFFINERGY, LLC1
- AVENTUSOFT, LLC1
- DXDISCOVERY, INC.1
- PLENOPTIKA, INC.1
- RESEARCH CIRCLE ASSOCIATES, LLC1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2017 | A mobile framework to measure ejection fraction by automated non-invasive analysis of cardiac signals2R44MD009556-03 | KALE, KAUSTUBH | AVENTUSOFT, LLC, FL | $400,000 | ZEB1 |
| 2017 | Improving access to vision correction for health disparity populations with the QuickSee: an accurate, low-cost, easy-to-use objective refractor1R43EB024299-01 | DAVE, SHIVANG RAJENDRADURR, NICHOLAS JAMES | PLENOPTIKA, INC., MA | $200,225 | ZEB1 |
| 2017 | Point-of-care device to identify patients at risk for preeclampsia1R43EB024288-01 | NAIR, SHRIKUMAR AMBUJAKSHAN | AFFINERGY, LLC, NC | $200,000 | ZEB1 |
| 2017 | Artificially Intelligent Diabetes Assistant (AIDA) for African Americans with Type 2 Diabetes1R43MD012223-01 | MCNASBY, MARK BRIAN | TARHEELVENTURES.COM, INC., NC | $199,928 | ZEB1 |
| 2017 | Facilitating Integration of HIV Prevention Strategies in Underserved Populations Through an mHealth Intervention1R43MD012222-01 | CALDWELL, DIANA HOWARD | RESEARCH CIRCLE ASSOCIATES, LLC, MD | $187,157 | ZEB1 |
| 2016 | Point of care immunoassay for rapid diagnosis of tinea capitis1R43EB023408-01 | BURNHAM-MARUSICH, AMANDAKOZEL, THOMAS R | DXDISCOVERY, INC., NV | $199,920 | ZEB1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.